ニュース

TipRanks on MSN9 時間

AbbVie’s Atogepant Study: A New Frontier in Pediatric Migraine Prevention

Abbvie (($ABBV)) announced an update on their ongoing clinical study. Study Overview: AbbVie is conducting a Phase 3 clinical ...
TipRanks on MSN9 時間

Gilead’s Promising Phase 3 Study on Sacituzumab Govitecan for Lung Cancer

Gilead Sciences (($GILD)) announced an update on their ongoing clinical study. Gilead Sciences is conducting a pivotal Phase 3 study titled A ...